Advanced search
1 file | 2.37 MB Add to list

Characterization of human recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in Pichia pastoris as potential enzyme for Mucopolysaccharidosis IVA treatment

Author
Organization

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 2.37 MB

Citation

Please use this url to cite or link to this publication:

MLA
Rodríguez-López, Alexander et al. “Characterization of Human Recombinant N-acetylgalactosamine-6-sulfate Sulfatase Produced in Pichia Pastoris as Potential Enzyme for Mucopolysaccharidosis IVA Treatment.” JOURNAL OF PHARMACEUTICAL SCIENCES (2019): n. pag. Print.
APA
Rodríguez-López, A., Pimentel-Vera, L. N., Espejo-Mojica, A. J., Van Hecke, A., Tiels, P., Tomatsu, S., Callewaert, N., et al. (2019). Characterization of human recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in Pichia pastoris as potential enzyme for Mucopolysaccharidosis IVA treatment. JOURNAL OF PHARMACEUTICAL SCIENCES.
Chicago author-date
Rodríguez-López, Alexander, Luisa N Pimentel-Vera, Angela J Espejo-Mojica, Annelies Van Hecke, Petra Tiels, Shunji Tomatsu, Nico Callewaert, and Carlos J Alméciga-Díaz. 2019. “Characterization of Human Recombinant N-acetylgalactosamine-6-sulfate Sulfatase Produced in Pichia Pastoris as Potential Enzyme for Mucopolysaccharidosis IVA Treatment.” Journal of Pharmaceutical Sciences.
Chicago author-date (all authors)
Rodríguez-López, Alexander, Luisa N Pimentel-Vera, Angela J Espejo-Mojica, Annelies Van Hecke, Petra Tiels, Shunji Tomatsu, Nico Callewaert, and Carlos J Alméciga-Díaz. 2019. “Characterization of Human Recombinant N-acetylgalactosamine-6-sulfate Sulfatase Produced in Pichia Pastoris as Potential Enzyme for Mucopolysaccharidosis IVA Treatment.” Journal of Pharmaceutical Sciences.
Vancouver
1.
Rodríguez-López A, Pimentel-Vera LN, Espejo-Mojica AJ, Van Hecke A, Tiels P, Tomatsu S, et al. Characterization of human recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in Pichia pastoris as potential enzyme for Mucopolysaccharidosis IVA treatment. JOURNAL OF PHARMACEUTICAL SCIENCES. 2019;
IEEE
[1]
A. Rodríguez-López et al., “Characterization of human recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in Pichia pastoris as potential enzyme for Mucopolysaccharidosis IVA treatment,” JOURNAL OF PHARMACEUTICAL SCIENCES, 2019.
@article{8612014,
  author       = {Rodríguez-López, Alexander and Pimentel-Vera, Luisa N and Espejo-Mojica, Angela J and Van Hecke, Annelies and Tiels, Petra and Tomatsu, Shunji and Callewaert, Nico and Alméciga-Díaz, Carlos J},
  issn         = {0022-3549},
  journal      = {JOURNAL OF PHARMACEUTICAL SCIENCES},
  language     = {eng},
  title        = {Characterization of human recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in Pichia pastoris as potential enzyme for Mucopolysaccharidosis IVA treatment},
  url          = {http://dx.doi.org/10.1016/j.xphs.2019.03.034},
  year         = {2019},
}

Altmetric
View in Altmetric